Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1445 of 6351
-
Pharmacists to the rescue: new study aims to protect kidneys in diabetes patients without a family doctor
Disease control Recruiting nowType 2 diabetes is the leading cause of chronic kidney disease, which can result in serious complications such as kidney failure and heart disease. Although effective medications exist to slow the progression of kidney damage, they are often underused in primary care, particularl…
Sponsor: Nova Scotia Health Authority • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
AI virtual coach aims to cut breast cancer risk through lifestyle changes
Prevention Recruiting nowBreast cancer (BC) is the most commonly diagnosed cancer in women worldwide, with early-onset cases increasing due to genetic and lifestyle factors. Traditional prevention strategies have shown limited effectiveness, creating the need for innovative approaches. The MELIORA projec…
Sponsor: Harokopio University • Aim: Prevention
Last updated Jun 27, 2026 14:00 UTC
-
New injection plus radiation shows promise against cervical cancer
Disease control Recruiting nowThis is a seamless Phase 1/2 study consisting of two components. Phase 1 component is a dose-escalation, single arm, open label study in 10 patients to evaluate the safety and tolerability of KRC 01. Phase 2 component is a randomized, open label, controlled, multi-center study in…
Phase 1 • Sponsor: Kortuc, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Could epilepsy and blood disorder drugs take on brain cancer?
Disease control Recruiting nowGlioblastoma is the most common and aggressive form of brain cancer in adults. Despite surgery, radiotherapy, and chemotherapy, most patients only live about one year after diagnosis. There is an urgent need for new and better treatments. Recent research has shown that glioblast…
Early phase 1 • Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Could a pill tame aggression in fragile x? new trial aims to find out
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if drug SRX246 works to treat irritability, agitation, aggression and self-injury (IAAS) behaviors in adult males with Fragile X Syndrome (FXS). It will also learn about the safety of drug SRX246. The main questions it aims to answer ar…
Phase 2 • Sponsor: Azevan Pharmaceuticals • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Precision radiation boosts cancer fight in Late-Stage esophageal study
Disease control Not yet recruitingParticipants in this study will have esophageal cancer that has spread (metastasized) to other parts of the body either at initial diagnosis (synchronous) or after the cancer returned following treatment (recurrent). In Alberta, the current standard approach for treating esophag…
Phase 2 • Sponsor: AHS Cancer Control Alberta • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Hypnosis may replace pills for Needle-Phobic kids
Symptom relief Not yet recruitingThe proposed study aims to evaluate the effectiveness of hypnotherapy as a non-pharmacological intervention for managing pain and anxiety during needle-related medical procedures in children aged 5 to 17 years. This research addresses a significant gap in pediatric healthcare, wh…
Sponsor: Aarhus University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:13 UTC
-
PET scan could sharpen radiation for returning brain tumors
Disease control Recruiting nowReciDOPA is a phase II, single-stage randomized, multicenter, prospective trial assessing the efficacy of an irradiation protocol based on Intensity-modulated radiation therapy with simultaneous-integrated boost guided by FDOPA-PET in patient with recurrent glioblastoma.
Phase 2 • Sponsor: Centre Paul Strauss • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
New nanoparticle drug aims to fight tough lung cancer
Disease control Recruiting nowThe purpose of the Phase 1 research is to test the safety, tolerability, maximum tolerated dose, and pharmacokinetics (PK- the study of how a medicine moves through subject body. It looks at how the drug is absorbed, travels in your blood, reaches different parts of subject body,…
Phase 1/2 • Sponsor: SN BioScience • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Eat your way to better mood? diet trial targets depression
Symptom relief Not yet recruitingThe objective of this study is to investigate the efficacy of a culturally-adapted Mediterranean diet, in accordance with clinical guidelines and research evidence, in reducing depressive symptoms among Hong Kong Chinese adults. Additionally, this study will also explore the pote…
Sponsor: Chinese University of Hong Kong • Aim: Symptom relief
Last updated Jun 27, 2026 09:09 UTC
-
New pill shows promise for arthritis patients who fail standard treatments
Disease control Not yet recruitingRheumatoid arthritis (RA) is a chronic autoimmune disease affecting small joints, with a global prevalence of 0.5%-1.0% and 0.42% in China (around 5 million patients, mostly female and over 55). By 2050, RA patients worldwide are estimated to reach 31.7 million, an 80.2% increase…
Phase 4 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Virtual reality meets AI: a new hope for stroke arm recovery?
Symptom relief Not yet recruitingBackground: Upper limb motor deficits are common after stroke, and early rehabilitation is crucial for functional recovery. Virtual reality (VR) combined with artificial intelligence (AI) has shown potential to enhance motor learning, but evidence from randomized controlled trial…
Sponsor: Complejo Asistencial Universitario de León Urgencias • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
New Stent-Graft for aortic aneurysm tested in Real-World registry
Disease control Recruiting nowObjective To pragmatically collect and analyze patient-level clinical, procedural, and outcome data from participating centers in Italy and Poland on the use of the PERCUTEK Tycheseal™ stent-graft system for the endovascular repair of abdominal aortic aneurysms. The study aims to…
Sponsor: American Heart of Poland • Aim: Disease control
Last updated Jun 27, 2026 11:04 UTC
-
Could one antibiotic replace two for chemo fevers? major trial launches
Disease control Not yet recruitingThe combination of amoxicillin-clavulanate (AC) and a fluoroquinolone (FQ) is currently recommended for the treatment for outpatients with hematologic malignancies presenting with chemotherapy-induced fever (CIF), if the expected duration of neutropenia is \< 7 days. However, inf…
Phase 3 • Sponsor: Versailles Hospital • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New obesity drug tirzepatide put to the test in paraguay clinic
Disease control Not yet recruitingThis is a Phase 4 observational study evaluating the safety and effectiveness of tirzepatide (T.G.) manufactured by INDUFAR S.A. in 300 patients with obesity treated at the Obesity Unit of Hospital de Clínicas in Paraguay over 12 months. The primary objective is to assess the saf…
Sponsor: LABORATORIOS INDUFAR • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Can pressurized oxygen calm the storm of PTSD?
Symptom relief Recruiting nowPost-traumatic stress disorder (PTSD), affecting approximately 6% of the general population and up to one-third of individuals exposed to combat zones and disasters, is a significant contributor to morbidity and mortality among IDF personnel. Hyperbaric oxygen therapy (HBOT), in …
Sponsor: Medical Corps, Israel Defense Force • Aim: Symptom relief
Last updated Jun 27, 2026 11:01 UTC
-
Can a calming drug tame the deadly stress of sepsis?
Disease control Not yet recruitingThe goal of this clinical trial is to learn whether early administration of dexmedetomidine can improve autonomic nervous system regulation and clinical outcomes in adult patients with septic shock. It will also evaluate the safety of dexmedetomidine in this population. The main…
Phase 4 • Sponsor: Sichuan Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Can a memory pill combo shield your brain from radiation?
Disease control Not yet recruitingThe study investigators are testing to see if patients receiving radiation treatment for brain cancer along with raloxifene plus memantidine take longer to develop memory issues. The study will include anyone over the age of 18 who will be treated with radiation for brain cancer…
Phase 2 • Sponsor: The University of Texas Health Science Center at San Antonio • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Heart attack drug may fix 'Hidden' vessel damage
Disease control Not yet recruitingDespite the success of restoration of epicardial blood flow by the primary percutaneous coronary intervention (PPCI), approximately one half of patients with ST-segment elevation myocardial infarction (STEMI) have failed myocardial reperfusion, namely microvascular dysfunction. P…
Phase 4 • Sponsor: China National Center for Cardiovascular Diseases • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New orthosis aims to stop shoulder dislocation in stroke survivors
Prevention OngoingStroke is a leading cause of long-term disability worldwide. During the early stage of recovery after cerebral infarction, reduced muscle tone and muscle weakness in the affected upper limb may lead to shoulder instability and shoulder subluxation, which can subsequently result i…
Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University • Aim: Prevention
Last updated Jul 02, 2026 00:00 UTC